Risk Factors for Community-associated Clostridium difficile-associated Diarrhea in Children

被引:26
|
作者
Crews, Jonathan D. [1 ,3 ]
Anderson, Lauren R. [2 ]
Waller, D. Kim [3 ]
Swartz, Michael D. [3 ]
DuPont, Hebert L. [3 ,4 ]
Starke, Jeffrey R. [2 ]
机构
[1] Baylor Coll Med, Pediat Infect Dis, San Antonio, TX USA
[2] Baylor Coll Med, Pediat Infect Dis, Houston, TX 77030 USA
[3] Univ Texas Sch Publ Hlth, Houston, TX USA
[4] Baylor St Lukes Med Ctr, Houston, TX USA
关键词
TERM-CARE FACILITY; UNITED-STATES; INFECTION; EPIDEMIOLOGY; DISEASE; SURVEILLANCE; RESIDENTS; ADULTS;
D O I
10.1097/INF.0000000000000767
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Clostridium difficile-associated diarrhea (CDAD) is increasingly diagnosed in children in community settings. This study aims to assess recent antibiotic use and other risk factors in children with community-associated (CA-) CDAD compared with children with other diarrheal illnesses in a tertiary care setting. Methods: Children with CA-CDAD evaluated at Texas Children's Hospital (Houston, TX) from January 1, 2012 to June 30, 2013 were identified. Two control subjects with community-associated diarrhea who tested negative for C. difficile were matched to case subjects. Data on demographics, medication exposure and outpatient healthcare encounters were collected from medical records. Multivariate logistic regression was performed to identify predictors of pediatric CA-CDAD. Results: Of 69 CA-CDAD cases, most (62.3%) had an underlying chronic medical condition and 40.6% had antibiotic exposure within 30 days of illness. However, no traditional risk factor for CDAD was identified in 23.2% and 15.9% of CA-CDAD cases within 30 and 90 days of illness onset, respectively. Outpatient healthcare encounters within 30 days were more common among CA-CDAD cases than control subjects (66.7% vs. 48.6%; P = 0.01). In the final multivariate model, CA-CDAD was associated with cephalosporin use within 30 days [odds ratio: 3.32; 95% confidence interval: 1.10-10.01] and the presence of a gastrointestinal feeding device (odds ratio: 2.59; 95% confidence interval: 1.07-6.30). Conclusions: Recent use of cephalosporins and the presence of gastrointestinal feeding devices are important risk factors for community- associated CDAD in children. Reduction in the use of outpatient antibiotics may decrease the burden of CA-CDAD in children.
引用
收藏
页码:919 / 923
页数:5
相关论文
共 50 条
  • [41] Distribution and risk factor analysis for Clostridium difficile-associated diarrhea among hospitalized children over one year of age
    Zhao, Chunna
    Guo, Shu
    Jia, Xiaoyun
    Xu, Xiwei
    PEDIATRIC INVESTIGATION, 2020, 4 (01) : 37 - 42
  • [42] Clostridium difficile-associated diarrhea from a general hospital in Argentina
    Legaria, MC
    Lumelsky, G
    Rosetti, S
    ANAEROBE, 2003, 9 (03) : 113 - 116
  • [43] Molecular analysis of relapses or reinfections of Clostridium difficile-associated diarrhea
    Sisto, Francesca
    Scaltrito, Maria Maddalena
    Zago, Miriam
    Bonomi, Arianna
    Cocce, Valentina
    Frugoni, Sergio
    NEW MICROBIOLOGICA, 2011, 34 (04) : 399 - 402
  • [44] Safety and efficacy of fidaxomicin in the treatment of Clostridium difficile-associated diarrhea
    Golan, Yoav
    Epstein, Lauren
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2012, 5 (06): : 395 - 402
  • [45] The Use of Probiotics in the Prevention and Treatment of Antibiotic-Associated Diarrhea With Special Interest in Clostridium difficile-Associated Diarrhea
    Rohde, Cynthia L.
    Bartolini, Vickie
    Jones, Nicole
    NUTRITION IN CLINICAL PRACTICE, 2009, 24 (01) : 33 - 40
  • [46] Community-associated Clostridium difficile infection in emergency department patients in Western Australia
    Collins, Deirdre A.
    Selvey, Linda A.
    Celenza, Antonio
    Riley, Thomas V.
    ANAEROBE, 2017, 48 : 121 - 125
  • [47] The Management of Clostridium difficile-associated Diarrhoea in a Community Hospital
    Tomkins, K.
    Raynor, J.
    Rothwell, L.
    DeSilva, J.
    Wilson, C.
    WEST INDIAN MEDICAL JOURNAL, 2011, 60 (01) : 57 - 60
  • [48] A 5-Year Retrospective Review of Experience With Clostridium difficile-Associated Diarrhea
    Armbruster, Steven
    Goldkind, Lawrence
    MILITARY MEDICINE, 2012, 177 (04) : 456 - 459
  • [49] Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile-Associated Diarrhea: A Phase 2a Multicenter Clinical Trial
    O'Gorman, Molly A.
    Michaels, Marian G.
    Kaplan, Sheldon L.
    Otley, Anthony
    Kociolek, Larry K.
    Hoffenberg, Edward J.
    Kim, Kwang Sik
    Nachman, Sharon
    Pfefferkorn, Marian D.
    Sentongo, Timothy
    Sullivan, Janice E.
    Sears, Pamela
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2018, 7 (03) : 210 - 218
  • [50] Clostridium difficile-associated Pouchitis
    Shen, Bo
    Goldblum, John R.
    Hull, Tracy L.
    Remzi, Feza H.
    Bennett, Ana E.
    Fazio, Victor W.
    DIGESTIVE DISEASES AND SCIENCES, 2006, 51 (12) : 2361 - 2364